WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a recognized leader in RNAi-based therapeutic discovery and development, today announced that it will release financial results for the quarter ended June 30, 2010 on Wednesday, August 11, 2010, before the U.S. financial markets open.
